ChemoCentryx ContactKeep Me PostedSite Map
Product Pipeline

Overview

CCR9 Program
Overview
PROTECT-1 Clinical Trial
IBD Advisory Board
IBD
Phase II Trial in Celiac Disease
Celiac Disease

Partnered Programs

CCR1 Program

Additional Programs

Partners

IBD Advisory Board

ChemoCentryx has established a world-class Clinical Advisory Board composed of some of the leaders in the field of inflammatory bowel disease.

Stephen Hanauer, M.D.
Professor of Medicine and Clinical Pharmacology and Chief, Section of Gastroenterology and Nutrition, University of Chicago Pritzker School of Medicine

Michael Kamm, M.D.
Professor of Gastroenterology and Director of Physiology Unit, St. Mark's Hospital, Harrow, England

William Sandborn, M.D.
Gastroenterology & Hepatology, Head, Inflammatory Bowel Disease, Mayo Clinic, Rochester, Minnesota

Stephen Targan, M.D.
Division Director of Gastroenterology, Inflammatory Bowel Disease Center and Immunobiology Institute, Cedars-Sinai Medical Center, Los Angeles, California

Sander van Deventer, M.D., Ph.D.
Professor of Gastroenterology; Academic Medical Center, University of Amsterdam, The Netherlands

^ Return to Top